Page last updated: 2024-11-06

6-methylthiopurine and Abnormalities, Drug-Induced

6-methylthiopurine has been researched along with Abnormalities, Drug-Induced in 1 studies

6-methylthiopurine : A thiopurine that is 9H-purine substituted by a methylsulfanyl group at position 6.

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
"Pregnancy has a major effect on maternal thiopurine metabolism."2.79Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. ( de Boer, NK; de Jong, DJ; Dijkstra, G; Hommes, DW; Jharap, B; Mulder, CJ; Oldenburg, B; Stokkers, P; van Bodegraven, AA; van der Woude, CJ; van Elburg, RM, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jharap, B1
de Boer, NK1
Stokkers, P1
Hommes, DW1
Oldenburg, B1
Dijkstra, G1
van der Woude, CJ1
de Jong, DJ1
Mulder, CJ1
van Elburg, RM1
van Bodegraven, AA1

Trials

1 trial available for 6-methylthiopurine and Abnormalities, Drug-Induced

ArticleYear
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Gut, 2014, Volume: 63, Issue:3

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anemia, Neonatal; Azathioprine; Biomarkers; Female;

2014